Ensysce Biosciences Inc (NASDAQ: ENSC) is -40.03% lower on its value in year-to-date trading and has touched a low of $0.14 and a high of $2.06 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ENSC stock was last observed hovering at around $0.71 in the last trading session, with the day’s loss setting it -0.07%.
Currently trading at $0.64, the stock is 22.35% and 73.04% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.09 million and changing -10.34% at the moment leaves the stock 11.14% off its SMA200. ENSC registered -25.66% loss for a year compared to 6-month loss of 0.90%. The firm has a 50-day simple moving average (SMA 50) of $0.36216 and a 200-day simple moving average (SMA200) of $0.576935.
The stock witnessed a 267.88% gain in the last 1 month and extending the period to 3 months gives it a 57.27%, and is -8.62% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.70% over the week and 28.30% over the month.
Ensysce Biosciences Inc (ENSC) has around 9 employees, a market worth around $12.45M and $4.42M in sales. Profit margin for the company is -179.29%. Distance from 52-week low is 350.21% and -69.14% from its 52-week high. The company has generated returns on investments over the last 12 months (-438.48%).
The EPS is expected to grow by 82.30% this year
14.0 institutions hold shares in Ensysce Biosciences Inc (ENSC), with institutional investors hold 22.53% of the company’s shares. The shares outstanding are 14.91M, and float is at 14.62M with Short Float at 43.47%. Institutions hold 22.26% of the Float.
The top institutional shareholder in the company is PLANTE MORAN FINANCIAL ADVISORS, LLC with over 20.0 shares valued at $10.0. The investor’s holdings represent 0.0004 of the ENSC Shares outstanding.
